Showing results (151-160 of 176) with videos related to

Sort By:
Pageof 18
Vaccine|April 5, 2021
Long-term persistent immunogenicity after successful standard and triple-dosed hepatitis B vaccine in hemodialysis patients: A 3-year follow-up study in ChinaTian Yao, Zhihong Shao, Lina Wu, et al.
Science in One Health|November 10, 2025
One Health for all: synergistic solutions advancing SDG3 through sustainable science and inclusive innovationJingshu Liu, Ne Qiang, Heya Yi, et al.
The Journal of Infectious Diseases|May 28, 2009
Evaluation of the impact of hepatitis B vaccination among children born during 1992-2005 in ChinaXiaofeng Liang, Shengli Bi, Weizhong Yang, et al.
Vaccine|September 5, 2009
Epidemiological serosurvey of hepatitis B in China--declining HBV prevalence due to hepatitis B vaccinationXiaofeng Liang, Shengli Bi, Weizhong Yang, et al.
Vaccine|May 30, 2021
Immunogenicity and persistence of high-dose recombinant hepatitis B vaccine in adults infected with human immunodeficiency virus in China: A randomized, double-blind, parallel controlled trialYongliang Feng, Tian Yao, Yue Chang, et al.
Vaccine|August 17, 2013
Reprint of: Epidemiological serosurvey of Hepatitis B in China--declining HBV prevalence due to Hepatitis B vaccinationXiaofeng Liang, Shengli Bi, Weizhong Yang, et al.
China CDC Weekly|March 31, 2022
When and How to Adjust Non-Pharmacological Interventions Concurrent with Booster Vaccinations Against COVID-19 - Guangdong, China, 2022Guanhao He, Fangfang Zeng, Jianpeng Xiao, et al.
Preventing Chronic Disease|May 24, 2014
Hypertension prevalence, awareness, treatment, and control and sodium intake in Shandong Province, China: baseline results from Shandong-Ministry of Health Action on Salt Reduction and Hypertension (SMASH), 2011Zhenqiang Bi, Xiaofeng Liang, Aiqiang Xu, et al.
Med (New York, N.Y.)|January 13, 2024
Ambient PM2.5 and cardiopulmonary mortality in the oldest-old people in China: A national time-stratified case-crossover studyCuiling Wu, Guanhao He, Wei Wu, et al.
The Journal of Infectious Diseases|October 8, 2024
Immunogenicity, Safety, and Persistence Induced by Triple- and Standard-Strength 4-Dose Hepatitis B Vaccination Regimens in Patients Receiving HemodialysisTian Yao, Yandi Li, Yidan Zhang, et al.
Pageof 18